Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2021
Committee Review
Floor Vote
Governor
Introduced Feb 18, 2021
Last action Apr 9, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
9
Key actions
3
Committee
3
Mar 11, 2021
Lower · Passed
Committee report, to adopt and re-refer to Ways and Means
lower
Mar 4, 2021
Lower · Passed
Committee report, to adopt as amended and re-refer to State Government Finance and Elections
lower
Feb 25, 2021
Lower · Passed
Committee report, to adopt as amended and re-refer to Health Finance and Policy
lower
Feb 18, 2021
Introduced
Introduction and first reading, referred to Commerce Finance and Policy
lower
1 primary · 3 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 1183
Scope: MN
Hi! I can help you understand HF 1183. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline